IndiaTickerSamrat Pharmachem Ltd-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Samrat Pharmachem
BSE:SAMRATPH · ISIN INE103E01016
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Samrat Pharmachem
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Notice Of Board Meeting For Un-Audited Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Audited Financial Results For The Quarter And Year Ended 31 March, 2026BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading WindowBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Un-Audited Financial Results For The Quarter Ended December 31, 2025BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Outcome for Outcome Of The Board Meeting Held TodayBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31, 2025BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading WindowBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Outcome for Outcome Of Board Meeting Held TodayBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2025BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30, 2025BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Book Closure: Friday, September 19, 2025 To Thursday, September 25, 2025 (Both Days Inclusive)BSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Record Date - Thursday, September 18, 2025BSE · corporate action · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday, September 25, 2025BSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Outcome for Outcome Of Board MeetingBSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Un-Audited Financial Results For The Quarter Ended June 30, 2025BSE · financial results · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Samrat Pharmachem Ltd-$ - 530125 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing